Trana-Zan Injection

Trana-Zan Injection contains Tranexamic Acid, an antifibrinolytic agent used to reduce excessive bleeding by inhibiting the breakdown of blood clots. It works by blocking plasminogen from binding to fibrin, preventing fibrinolysis and stabilising clots to decrease blood loss.​

By promoting clot stability, Tranexamic Acid effectively reduces menstrual blood flow and controls haemorrhage in surgical or traumatic settings. This action minimises blood loss and reduces the need for transfusions. In women with heavy periods, it provides significant relief, improving the quality of life.

Trana-Zan Injection is also used to manage bleeding episodes in haemophilia patients and during dental procedures in those with clotting disorders. Effects begin within hours of administration, with peak benefits during active bleeding episodes. Tranexamic Acid is primarily eliminated through the kidneys, requiring dose adjustments in patients with renal impairment. When used as prescribed, Trana-Zan Injection offers effective bleeding control with a favourable safety profile for short-term use.

Heavy Menstrual Bleeding

Primary treatment for women experiencing excessive menstrual blood loss (menorrhagia) that interferes with daily activities. Trana-Zan Injection significantly reduces flow during periods, often by 30-60%, improving quality of life and reducing anaemia risk.

Haemophilia Management

Essential for controlling spontaneous or injury-related bleeding episodes in patients with haemophilia A or B. Helps prevent prolonged bleeding after minor trauma or dental work by stabilising clots in these clotting factor-deficient patients.

Surgical Bleeding

Reduces blood loss during surgical procedures, especially dental extractions in haemophilia patients or those on anticoagulants. Preoperative and postoperative dosing minimises transfusion needs and speeds recovery.

Trauma Care

Critical supportive treatment in trauma patients with life-threatening haemorrhage from accidents or injuries. Rapid administration reduces mortality by stabilising clots in active bleeding sites throughout the body.

Traumatic Bleeding

Provides immediate control of bleeding from wounds, fractures, or soft tissue injuries in emergency settings. Particularly valuable when blood transfusions are unavailable or delayed.

• Rapid Bleeding Control: Quickly reduces heavy menstrual flow and surgical bleeding.

• Non-Hormonal Option: Safe for women who cannot use hormonal treatments.

• Reduces Transfusion Need: Minimises blood transfusion requirements in bleeding patients.

• Well-Tolerated: Generally safe for short-term use with minimal systemic effects.

• Versatile Use: Effective across multiple bleeding conditions and patient types.

While Trana-Zan Injection is generally well-tolerated, some patients may experience side effects as their body adjusts to the medication.

Common Side Effects:

• Headache: Mild to moderate headaches or migraines.

• Stomach Pain: Abdominal discomfort or nausea.

• Joint/Muscle Pain: Back pain, muscle cramps, or joint discomfort.

• Sinus Symptoms: Nasal congestion or runny nose.

• Fatigue: General tiredness or low energy.

Uncommon Side Effects:

• Anaemia: Low red blood cell levels from ongoing bleeding.

• Digestive Issues: Vomiting, diarrhoea, or mild gastrointestinal upset.

• Vision Changes: Temporary blurry vision or colour perception changes.

• Skin Reactions: Mild rash or itching.

Serious Side Effects (Require Immediate Medical Attention):

• Blood Clots: Chest pain, leg swelling, shortness of breath, or sudden weakness.

• Allergic Reactions: Swelling of the face/lips/tongue, difficulty breathing, or severe rash.

• Severe Vision Problems: Persistent vision changes, eye pain, or light sensitivity.

• Seizures: Rare convulsions, particularly with high doses or improper administration.

Trana-Zan Injection should be taken exactly as prescribed by your doctor. The tablets are usually taken once daily, with or without food, and often alongside aspirin. It is important to take the medicine at the same time each day to maintain consistent platelet inhibition. Swallow the tablet whole with a glass of water. Do not stop taking the medication suddenly, as this can increase the risk of heart attack or blood clots; if you need to discontinue, your doctor will provide guidance.

The mechanism of Trana-Zan Injection involves irreversible inhibition of the P2Y12 ADP receptor on platelets. ADP is a key activator in the platelet aggregation process that leads to clot formation. By blocking these receptors, Trana-Zan Injection prevents platelet activation and aggregation, reducing the formation of harmful blood clots in arteries. This action decreases the risk of thrombotic cardiovascular events following acute coronary syndrome or stent placement.​

• Monitor for Bleeding: Watch for unusual bruising, nosebleeds, or blood in urine/stool; report immediately to your doctor.

• Aspirin Combination: Always take with aspirin as prescribed to maximise heart protection.

• Procedure Planning: Inform healthcare providers before surgery or dental work; may need to pause 5-7 days prior.

• Regular Check-ups: Attend follow-ups for blood tests to monitor platelet function and overall health.

• Injury Prevention: Use caution with sharp objects or contact sports due to bleeding risk.

• Grapefruit Juice (MODERATE): May slightly increase drug levels; limit intake if advised by your doctor.

• Alcohol (SEVERE): Increases bleeding risk significantly; avoid heavy consumption.​

• NSAIDs (e.g., Ibuprofen) (MODERATE): Increases bleeding risk; use the lowest dose if necessary.

• Other Anticoagulants (SEVERE): Combining with warfarin, heparin, or other antiplatelets greatly heightens bleeding.

• SSRIs (e.g., Sertraline) (MODERATE): May increase bleeding risk; monitor closely.

• Opioids (MILD): Can delay absorption; take Trana-Zan Injection first if possible.

• Active Bleeding (SEVERE): Contraindicated in current ulcers, intracranial haemorrhage, or severe liver disease.

• History of Stroke/TIA (SEVERE): Increased risk of recurrent stroke; generally avoid.

• Thrombocytopenia (MODERATE): May worsen low platelet counts; requires monitoring.

If you miss a dose, take it as soon as you remember. However, if it is almost time for your next scheduled dose, skip the missed dose and continue with your regular routine. Never take two doses at the same time to compensate for a missed one, as this can increase bleeding risk.